Cystic Fibrosis

Steroid therapy may raise risk of infection with nontuberculous mycobacteria

Published in TB and Outbreaks Week, April 12th, 2005

Steroid therapy may increase the risk of infection with nontuberculous mycobacteria (NTM) in cystic fibrosis (CF) patients.

NTM infection, "particularly due to Mycobacterium abscessus, is an emerging disease that can be relentlessly progressive," particularly in CF patients, scientists in Israel explained.

In a study conducted by H. Mussaffi and colleagues at the Graub Cystic Fibrosis Center in Petah Tiqwa, the "risk factors that were associated with this increasingly symptomatic infection in a group of CF patients were investigated."

"A total of 139 CF patients aged 2-52 yrs were reviewed," the collaborators wrote in the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2005-04-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry